New diabetes drug shows promise in early human tests
NCT ID NCT06685185
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 27 times
Summary
This early study tested a new medicine called NNC0363-1063 in 117 people, including healthy volunteers and those with type 1 diabetes. The goal was to check safety, how the body processes the drug, and its effects on blood sugar. It is a first step to see if this drug could become a future treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Profil Institut für Stoffwechselforschung GmbH
Neuss, 41460, Germany
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NNC0363-1063
What this could lead to
If successful, this could point toward a new treatment option for type 1 diabetes that helps manage blood sugar levels.
What could go wrong
This is a very early Phase 1 trial, so the main goal is safety, not effectiveness. The drug may not work as hoped or could have side effects.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.